# Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/response-to-crizotinib-in-advanced-alk-rearranged-non-small-cell-lung-cancers/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yan Li,Tongtong Zhang,Jing Zhang,Wenbin Li,Pei Yuan,Puyuan Xing,Zhou Zhang,Shannon Chuai,Junling Li,Jianming Ying |
| Citations | 67 |
| DOI | 10.1016/j.lungcan.2018.01.026 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2793611408 |
| PMID | 29571990 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Puyuan Xing](https://scholariq.org/researchers/puyuan-xing/)

## Paper journal

- [Lung Cancer](https://scholariq.org/journals/lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.